arrow
J

Jeroen Dekervel

university hospitals leuven
H指数:24
被引数:3,344

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

胆道癌患者接受化疗免疫疗法治疗后不良事件预测作用的全球人群研究

Cancers
IF4.4
2026-09-100
OA
Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. Cancers 2026, 18, 1037

更正:Prisciandaro等人. 解剖性肺转移切除与非解剖性肺转移切除:欧洲多中心分析. Cancers 2026, 18, 1037

Cancers
IF4.4
2026-05-210
OA
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab

接受顺铂、吉西他滨和度鲁特韦治疗的胆道癌患者中,转移部位对预后的影响

2026-02-270
PRE
ECCO Topical Review on IBD-like patterns of drug colitis with practical guidance and a focus on immune checkpoint inhibitors

ECCO 专题综述:药物性结肠炎的炎症性肠病样模式,实用指南及免疫检查点抑制剂的聚焦

2026-01-010
PRE
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment

解码肿瘤异质性:一项关于肿瘤微环境的基于空间信息的泛癌分析

2025-10-140
OAAI
Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab

基因组通路改变及其在胆道癌中的预后影响:来自接受顺铂、吉西他滨和度伐利尤单抗治疗的跨国队列的见解

2025-10-030
PRE
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population

接受顺铂、吉西他滨和度伐利尤单抗治疗的晚期胆道癌患者中分子改变的影响:一项大型、真实世界、全球性人群研究

2025-09-011
PRE
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
2024-11-211
PRE
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
2024-11-010
OAAI
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
2024-10-010
OAAI
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

Durvalumab联合吉西他滨和顺铂治疗晚期胆道癌: 大量现实世界人口

2024-09-013
PRE